Prostate-specific antigen (PSA) test from the blood serum is one of the routine screening procedures for the detection of prostate cancer; however, the sensitivity and the specificity are significantly lower than the desired accuracy for cancer diagnosis [153,154]. This evidence concerns the gene KLK3 and prostate cancer.